Stephanie Diez de Sollano: Recognition and Management of Ehlers-Danlos Syndrome
Stephanie Diez de Sollano, Health Care Professional at Stanford Health Care, shared a post on LinkedIn.
Ehlers-Danlos Syndrome (EDS) is a group of rare, inherited connective tissue disorders that affect the body’s ability to produce collagen, leading to hypermobility, skin fragility, and a range of debilitating symptoms.
This condition, often undiagnosed or misdiagnosed, significantly impacts the lives of those affected.
Individuals with EDS experience joint hypermobility, chronic pain, skin that bruises easily, fatigue, and in severe cases, life-threatening complications.
The spectrum of EDS subtypes includes classical, hypermobile, vascular, and others, each with distinct features and severity.
The challenges of EDS extend beyond the physical.
Mental health struggles, including anxiety and depression, often accompany the chronic pain and uncertainty of the condition.
The lack of awareness and understanding in society further complicates the daily lives of those with EDS, as the condition is often misunderstood or overlooked.”
Stay updated with Hemostasis Today.
-
May 30, 2026, 18:12Khokon Miah Akanda: FDA Approves a First-in-Class Hypertension Drug
-
May 30, 2026, 18:11Alessandro Perrella: It is Not Only about “How High the CRP is”, but “in Which Patient” We are Measuring That Value
-
May 30, 2026, 18:11Jasper van Grunsven: Grateful for Our Rare Disease Team and the Commitment That Drives Our Mission
-
May 30, 2026, 18:10Open Registration for the 2026 Thrombosis Canada Annual Education Conference – Thrombosis Canada
-
May 30, 2026, 18:09Peter Zdziarski: Approval Does Not Mean NovoSeven is 100% Effective or Risk-Free in GT
-
May 30, 2026, 17:07Deepak Yadav: A Privilege to Talk on ESUS at CREST Stroke Conclave 2026
-
May 30, 2026, 16:59Syed A Rizvi: Medical Scoring Systems – Small Numbers, Big Clinical Decisions
-
May 30, 2026, 16:53Timothy “Tim” Sheehan: BNY Wealth Joins the Fight Against Blood Disorders In Support of Hemophilia of Georgia
-
May 30, 2026, 16:51Nouf Bahri: Anticoagulation Initiation for New-Onset Atrial Fibrillation in Critical Illness